221 related articles for article (PubMed ID: 24877113)
1. BMPs as therapeutic targets and biomarkers in astrocytic glioma.
González-Gómez P; Anselmo NP; Mira H
Biomed Res Int; 2014; 2014():549742. PubMed ID: 24877113
[TBL] [Abstract][Full Text] [Related]
2. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
[TBL] [Abstract][Full Text] [Related]
3. Selective calcium sensitivity in immature glioma cancer stem cells.
Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
[TBL] [Abstract][Full Text] [Related]
4. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
5. PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma-initiating cell properties via DNA methyltransferase 3A.
Tanabe R; Miyazono K; Todo T; Saito N; Iwata C; Komuro A; Sakai S; Raja E; Koinuma D; Morikawa M; Westermark B; Heldin CH
Mol Oncol; 2022 Jan; 16(1):269-288. PubMed ID: 34214250
[TBL] [Abstract][Full Text] [Related]
6. Isolation of Glioma-Initiating Cells for Biological Study.
Hu J; Markowitz G; Wang XF
Adv Exp Med Biol; 2016; 899():197-209. PubMed ID: 27325268
[TBL] [Abstract][Full Text] [Related]
7. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
Raja E; Komuro A; Tanabe R; Sakai S; Ino Y; Saito N; Todo T; Morikawa M; Aburatani H; Koinuma D; Iwata C; Miyazono K
Oncogene; 2017 Aug; 36(35):4963-4974. PubMed ID: 28459464
[TBL] [Abstract][Full Text] [Related]
9. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
[TBL] [Abstract][Full Text] [Related]
10. BMPing off glioma stem cells.
Nakano I; Saigusa K; Kornblum HI
Cancer Cell; 2008 Jan; 13(1):3-4. PubMed ID: 18167333
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
[TBL] [Abstract][Full Text] [Related]
12. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
[TBL] [Abstract][Full Text] [Related]
13. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
[TBL] [Abstract][Full Text] [Related]
14. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.
Jiang Y; Boije M; Westermark B; Uhrbom L
Neoplasia; 2011 Jun; 13(6):492-503. PubMed ID: 21677873
[TBL] [Abstract][Full Text] [Related]
15. Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin.
Langenfeld E; Deen M; Zachariah E; Langenfeld J
Mol Cancer; 2013 Oct; 12(1):129. PubMed ID: 24160469
[TBL] [Abstract][Full Text] [Related]
16. BMP signaling and its paradoxical effects in tumorigenesis and dissemination.
Zhang L; Ye Y; Long X; Xiao P; Ren X; Yu J
Oncotarget; 2016 Nov; 7(47):78206-78218. PubMed ID: 27661009
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
18. Mouse induced glioma-initiating cell models and therapeutic targets.
Kondo T
Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
[TBL] [Abstract][Full Text] [Related]
19. Chromatin Remodeling Factor BRG1 Regulates Stemness and Chemosensitivity of Glioma Initiating Cells.
Ganguly D; Sims M; Cai C; Fan M; Pfeffer LM
Stem Cells; 2018 Dec; 36(12):1804-1815. PubMed ID: 30171737
[TBL] [Abstract][Full Text] [Related]
20. BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells.
Srikanth M; Kim J; Das S; Kessler JA
Mol Cancer Res; 2014 Feb; 12(2):283-94. PubMed ID: 24269952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
